Brian Varnum
Keine laufenden Positionen mehr
Vermögen: 98 605 $ am 30.04.2024
Karriereverlauf von Brian Varnum
Ehemalige bekannte Positionen von Brian Varnum
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 02.08.2021 | 11.07.2023 |
| Vorstandsvorsitzender | 02.08.2021 | 11.07.2023 | |
| Präsident | 09.05.2019 | 02.08.2021 | |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01.03.2012 | 01.05.2019 |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Corporate Officer/Principal | 01.01.2012 | - |
Ausbildung von Brian Varnum
| University of California | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
C3 Jian LLC
C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
- Börse
- Insiders
- Brian Varnum
- Erfahrung
